Knowledge · Use Cases

Where agentic AI earns its place.

Across the deal contexts and industries that cannot afford to get this wrong, one pattern holds: the AI that wins is the AI someone runs to a standard. These are the use cases we are built for — where we advise, build, operate, and assure agentic systems against the problems that move the business.

Six places we put it to work.

By deal context & industry

The deal, the growth company, regulated science, the plant floor, and the clinic each reach for agentic AI from a different direction. Here is where the value sits in each — and what it takes to run it.

Private Equity · Value Creation

One AI operating program, across the portfolio

The opportunity

AI value is real but uneven across a portfolio — every company reinvents it, governance is inconsistent, and the gain rarely survives to exit.

Our approach

One operating playbook run across holdings, diligence to exit, with shared governance and unit economics — so AI becomes a standardized lever, not a per-company experiment.

The outcome we operate toward

Margin and EBITDA improvement that is attributable, defensible in a data room, and durable past the next owner.

M&A · Diligence to Integration

AI that de-risks the deal, both sides of close

The opportunity

Diligence on a target's AI and data estate is shallow, and post-close integration of those systems is where synergy quietly dies.

Our approach

Agents put to work in the data room — analyzing the estate, pressure-testing synergy assumptions — then we operate the integration so the AI and data merge rather than merely coexist.

The outcome we operate toward

Faster, more confident diligence and an integration that holds — synergy that survives contact with production.

Venture & Growth

A senior AI operations team, years before you could hire one

The opportunity

A growth company sees where AI should run its operations but cannot yet hire the senior team — and a year of recruiting is a year of falling behind.

Our approach

We become the AI operations function they would otherwise build — designing, building, and operating production AI as a managed service, scaling the company without scaling premature headcount.

The outcome we operate toward

Production AI at a level the team couldn't reach alone — available now, operated by a senior team.

Life Sciences

Regulated content, at the speed of research

The opportunity

Medical, regulatory, and safety writing moves at the speed of scarce experts — evidence synthesis, submissions, and pharmacovigilance under a standard where an error is not an option.

Our approach

Multi-agent systems that draft, cite, and cross-check against source — every regulated output traceable to its evidence, validated to a GxP-grade standard, with a human signing where the rules require it.

The outcome we operate toward

Submission and safety workflows that move faster without surrendering the audit trail the regulator and the medical reviewer both trust.

Manufacturing

An operating layer over the plant floor

The opportunity

Supply-chain, quality, and maintenance data already span ERP, MES, and sensors — but the signal that would prevent a disruption arrives after it.

Our approach

Agents that reason across those systems in real time, anticipate disruption, draft the corrective action, and route it to the right human — operated continuously, with cost-to-serve watched as closely as throughput.

The outcome we operate toward

Fewer surprises, faster root-cause, and margin protected — AI that runs alongside operations, not in a quarterly report.

Health Care

Lifting the administrative weight, safely

The opportunity

Prior authorization, revenue cycle, and documentation consume staff who should be on care — yet that load touches PHI and clinical risk, so automation has to be governed, not improvised.

Our approach

Agentic systems that carry the administrative load under strict HIPAA-grade governance and audit — human oversight on anything that touches a clinical decision, never inside it.

The outcome we operate toward

Administrative burden down and compliance protected — capacity returned to clinicians without putting the institution's standard at risk.

How we measure success

Held to a standard, not a demo.

An impressive demo is not success. Production performance against a defined bar, at a cost that holds, is. Three measures decide it.

Outcome to standard

Did it meet the bar?

Performance judged against the outcome the client hired us to deliver — defined up front, in their terms, not against a benchmark we chose for ourselves.

Cost discipline

What did it cost to hold?

The unit economics are watched alongside the result. An outcome that only works while the bill is ignored is not an outcome we count.

Accountability

Who answers for it?

A named operator owns how the system performs in production — when something moves, there is a person to call, not a dashboard.

Begin with a Charter

Start with the problem, not the pitch.

A Charter is a short, fixed-fee diagnostic — the fastest way to turn one of these use cases into a mandate scoped to your own numbers, with the people who would run it.

Begin with a Charter → Talk to an expert